US-headquartered NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commerci...
10x Genomics, Inc., a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GI...
China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....
CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partners...
Japan-headquartered Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately&nb...
Over the last 50 years, Switzerland has emerged as one of the most innovative and collaborative biotech hubs in the worl...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of India-based Biocon Ltd. has ...
South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financ...
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers ...
A new device combining ultrasound and advanced imaging to provide crucial information for the safe delivery of drugs int...
The Albanese Government has awarded nearly $100 million in funding to three organisations for emerging Australian biomed...
Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing soluti...
Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...
Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
At the 2025 China–New Zealand Trade Innovation Summit, New Zealand Prime Minister, Christopher Luxon, witnessed th...
Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across disea...
AN Venture Partners (ANV), a global biotech venture capital firm, has announced the final close of its first fund, AN Ve...
